At frog neuromuscular junction, noradrenaline (NA) shortens the release per
iod for evoked quantal release acting on a beta 1 receptor. To test the hyp
othesis that this action of NA is mediated by cAMP, we measured the latenci
es of focally recorded uni-quantal endplate currents (EPCs) after applicati
on of dibutyryl-cAMP (db-cAMP) and adenylyl cyclase activator, forskolin. T
he interval between the time when responses with minimal delay appeared and
the point at which 90% of all latencies had occurred (P-90 parameter) was
shortened in the presence of both 1x10(-6) mol/l db-cAMP and 1x 10(-6) mol/
l forskolin by about 30%. The cAMP-induced shortening is equal to that foun
d after application of NA and effects of both drugs are not additive.